Receive a complete Daily History of this Stock You can receive a complete daily file of this issue since 1970 or stock inception. We will email you the file in ASCII format within a few hours or ordering. Product Details | Order

Business Description
Becton, Dickinson and Company (BD) is engaged principally in the manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD's operations consist of three segments: Medical Systems, Clinical Laboratory Solutions and Biosciences. Major products in the Medical Systems segment are hypodermic syringes and needles for injection, insulin syringes and pen needles for diabetes care, infusion therapy devices, prefillable drug delivery systems and surgical blades and scalpels. Major products in the Clinical Laboratory Solutions segment are clinical and industrial microbiology products, sample collection products, specimen management systems, hemotology instruments and other diagnostic systems. The Biosciences segment provides integrated systems, products and services for a variety of applications in life sciences.

Financial Information
Becton, Dickinson and Company manufactures and sells a broad line of supplies, devices and systems used by health care professionals, medical research institutions and the general public. For the nine months ended 6/30/02, revenues rose 7% to $2.96 billion. Net income applicable to Common before acct. change rose 14% to $346.7 million. Results reflect higher sales of safety-engineered devices, the growth of worldwide prefillable drug delivery devices and lower interest costs.